课题基金 / 基金详情

Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use

Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use
联盟旨在改善艾滋病毒/艾滋病、酒精和老龄化方面的成果
批准号:
8718951
负责人:
Ronald Scott Braithwaite
金额:
$21.83万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-06 至 2016-08-31

项目摘要

项目成果

Ronald Scott Braithwaite的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): HIV infects over 50,000 new people each year in the US. An important reason why HIV transmission persists is not because of an absence of potentially effective interventions, but rather because effective interventions are often not implemented. To address this problem, we have created a proposal that integrates comparative effectiveness research (which compares the effectiveness of different interventions) and operations research (which compares alternative portfolios of interventions, rather than comparing single interventions in isolation). We place particular emphasis on alcohol because it is a common modifiable risk factor for HIV transmission and is a common modifiable risk factor for HIV progression. Because unsafe alcohol use often occurs together with multi-substance use (MSU) and depression, because they often act on similar pathways to impact HIV transmission, our proposal considers portfolios of interventions that can address these oft-intertwined behaviors simultaneously or in a sequenced, prioritized progression. We also consider intervention designs that can be further tailored based on individual patient characteristics such as age and comorbidity burden. We seek to implement this operations research model within an interactive web-based laboratory that aims to improve research methods by encouraging greater "cross-talk" between modeling, observational data analysis, and trial design; and by identify patient groups that may particularly benefit from interventions, or tailoring results to the needs of particular stakeholders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Could long-acting medications facilitate "ending AIDS by 2030" in southern Africa? An allocative efficiency analysis
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal
海外基金